Adagrasib shows promising clinical activity in heavily pretreated KRAS-mutated CRC

Presented By

Dr Jared Weiss, University of North Carolina at Chapel Hill, NC, USA

Trial

Phase 1/2, KRYSTAL-1

Conference

ESMO 2021

19 November, 2021 09:42

Maintenance treatment with cetuximab versus observation in RAS wildtype mCRC

Presented By

Dr Valérie Boige, Institut Gustave Roussy, France

Trial

Phase 2, PRODIGE 28-time UNICANCER

Conference

ASCO GI 2021

12 March, 2021 11:33

Conference

ESMO 2020

25 November, 2020 15:13

Presented By

Prof. Scott Kopetz, MD Anderson Cancer Center, Houston, USA

Trial

Phase 3, BEACON CRC

Conference

ESMO 2019

26 November, 2019 14:22